Business Details
21 Years
experience
Innovative Cancer Research & Phase I Clinical Trials in Huntersville, NC
Founded in 2005, Carolina BioOncology Institute has pioneered a transformative approach to cancer care by bridging laboratory research with clinical application. Our mission focuses on expanding access to groundbreaking treatments through Phase I clinical trials conducted in a community-based setting. With on-site CLIA-certified laboratory capabilities, we provide comprehensive diagnostic services and specialized immunology testing. Our unique business model integrates curated clinical trial access with advanced research infrastructure, enabling rapid patient enrollment and high-quality care delivery. The institute's team combines decades of oncology expertise with cutting-edge translational research experience, maintaining compliance with GDP, GLP, and cGMP regulations. We collaborate with biopharmaceutical sponsors through our Human Applications Lab, offering cell processing and technology transfer services.Recognized for our AABB-accredited facilities, we contribute to global cancer research networks while maintaining local community engagement. Our participation in AbbVie's Phase I Partnerships for Excellence in Research network underscores our leadership in oncology innovation. Through strategic collaborations like the National Minority Quality Forum's biorepository initiative, we advance precision medicine while addressing healthcare disparities. Our leadership team brings extensive academic and clinical backgrounds, with members trained at institutions including Georgetown Medical School, MD Anderson Cancer Center, and Fox Chase Cancer Center.
Services
Phase I Immunotherapy Trials
CLIA Laboratory Services
Contract Research
BioSample Sourcing
Translational Analytical Services
Details
- Year established: 2005
Highlights and features
- We offer Phase I clinical trial capabilities established in 2005 with rapid patient enrollment
- Our CLIA-certified laboratory provides advanced diagnostic services including immunology testing
- AABB-accredited facilities ensure highest standards in cellular therapy research
- Team includes board-certified oncologists with specialized immunotherapy expertise
- Integrated research-clinic model accelerates translation of laboratory discoveries to patient care
Associations and certifications
- AABB
- CLIA
Services
Phase I Immunotherapy Trials
Our Phase I Immunotherapy Trials program specializes in early-stage cancer treatment research. We offer rapid patient enrollment and community-based clinical care for experimental immunotherapies. The program integrates laboratory research with clinical application to accelerate treatment development.
CLIA Laboratory Services
Our CLIA-certified laboratory provides comprehensive diagnostic testing including hematology, metabolic panels, and specialized immunology assays. We offer CELLSEARCH CTC enumeration and high-complexity diagnostic services with COLA accreditation and API proficiency testing.
Contract Research
Human Applications Lab offers contract research services for biopharmaceutical sponsors. Our capabilities include cell processing, technology transfer, and IND-enabling solutions under GDP, GLP, and cGMP regulations with experienced research staff.
BioSample Sourcing
We provide research-use-only biospecimens through IRB-approved protocols. Our collection processes include proper consent procedures and controlled-rate freezing for specimen preservation with extensive cryostorage capabilities.
Translational Analytical Services
Our analytical services combine immunology expertise with advanced technology for cell characterization. We offer flow cytometry, live cell imaging, and potency assays to support preclinical research and development activities.
People
Dr. John Powderly
Founder, President, and Oncologist
Board-certified oncologist with 20+ years immunotherapy experience. Trained at Georgetown Medical School, MD Anderson Cancer Center, and UNC Chapel Hill. Specializes in dendritic cell immunotherapy and early-phase cancer research.
Sherene Banawan
Physician Assistant
PA-C with oncology specialization and molecular biology expertise. Former Medical Laboratory Scientist with Atrium Health. Provides compassionate patient care and clinical support for immunotherapy trials.
Dr. Neel Gandhi
Oncologist & Hematologist
Board-certified hematologist-oncologist with 15+ years clinical experience. Former Director of Neuro-Oncology at Capital Health Medical Center. Specializes in brain tumor immunotherapy and Phase I trial development.
Questions
What clinical trials are currently available at Carolina BioOncology Institute?
We offer Phase I immunotherapy trials focused on solid tumors. Visit our website or contact us directly for current trial listings and eligibility information.
Do you provide diagnostic laboratory services?
Yes, our CLIA-certified laboratory offers hematology, metabolic testing, and specialized immunology assays including CELLSEARCH CTC enumeration and COVID-19 screening.
How can I schedule a consultation with your oncology team?
Complete our online appointment request form or call us at (704) 947-6599. A patient representative will contact you within one business day.
What research partnerships does the institute maintain?
We collaborate with AbbVie's P1PER network, National Minority Quality Forum, and Atrium Health. Our AABB-accredited facilities support global cancer research initiatives.
Are you accepting new patients for immunotherapy trials?
Eligibility varies by trial. Contact our patient services team to discuss current opportunities and determine if you qualify for any active studies.
Videos
